<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37508548</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1884</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12141884</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease with limited treatment options. Diagnosis can be difficult due to the heterogeneity and non-specific nature of the initial symptoms, resulting in delays that compromise prompt access to effective therapeutic strategies. Transcriptome profiling of patient-derived peripheral cells represents a valuable benchmark in overcoming such challenges, providing the opportunity to identify molecular diagnostic signatures. In this study, we characterized transcriptome changes in skin fibroblasts of sporadic ALS patients (sALS) and controls and evaluated their utility as a molecular classifier for ALS diagnosis. Our analysis identified 277 differentially expressed transcripts predominantly involved in transcriptional regulation, synaptic transmission, and the inflammatory response. A support vector machine classifier based on this 277-gene signature was developed to discriminate patients with sALS from controls, showing significant predictive power in both the discovery dataset and in six independent publicly available gene expression datasets obtained from different sALS tissue/cell samples. Taken together, our findings support the utility of transcriptional signatures in peripheral cells as valuable biomarkers for the diagnosis of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council (CNR-IRIB), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Cognata</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council (CNR-IRIB), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarnaccia</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council (CNR-IRIB), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Bella</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2045-1864</Identifier><AffiliationInfo><Affiliation>ALS Clinical Research Center and Neurochemistry Laboratory, BiND, University of Palermo, 90133 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conforti</LastName><ForeName>Francesca Luisa</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0001-8364-1783</Identifier><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7590-1792</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council (CNR-IRIB), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">class prediction</Keyword><Keyword MajorTopicYN="N">disease diagnosis</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">molecular signature</Keyword><Keyword MajorTopicYN="N">network</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37508548</ArticleId><ArticleId IdType="pmc">PMC10378077</ArticleId><ArticleId IdType="doi">10.3390/cells12141884</ArticleId><ArticleId IdType="pii">cells12141884</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brenner D., Freischmidt A. Update on genetics of amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2022;35:672&#x2013;677. doi: 10.1097/wco.0000000000001093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000001093</ArticleId><ArticleId IdType="pubmed">35942673</ArticleId></ArticleIdList></Reference><Reference><Citation>Smukowski S.N., Maioli H., Latimer C.S., Bird T.D., Jayadev S., Valdmanis P.N. Progress in Amyotrophic Lateral Sclerosis Gene Discovery. Neurol. Genet. 2022;8:e669. doi: 10.1212/NXG.0000000000000669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000669</ArticleId><ArticleId IdType="pmc">PMC9128037</ArticleId><ArticleId IdType="pubmed">35620141</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura M.C., Novaes M.R.C.G., Eduardo E.J., Zago Y.S.S.P., Freitas R.D.N.B., Casulari L.A. Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLoS ONE. 2015;10:e0141500. doi: 10.1371/journal.pone.0141500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141500</ArticleId><ArticleId IdType="pmc">PMC4627754</ArticleId><ArticleId IdType="pubmed">26517122</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Sub-committee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J. Neurol. Sci. 1994;124:96&#x2013;107. doi: 10.1016/0022-510x(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., Mills K., Mitsumoto H., Nodera H., Shefner J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Munsat T.L., Swash M., Brooks B.R. Consensus guidelines for the design and implementation of clinical trials in ALS. J. Neurol. Sci. 1999;169:2&#x2013;12. doi: 10.1016/S0022-510X(99)00209-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00209-9</ArticleId><ArticleId IdType="pubmed">10540001</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Al-Chalabi A., Baker M.R., Cui L.-Y., de Carvalho M., Eisen A., Grosskreutz J., Hardiman O., Henderson R., Matamala J.M., et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadena K., Vlamos P. The Importance of Diagnostic and Prognostic Biomarker Identification and Classification towards Understanding ALS Pathogenesis. Springer International Publishing; Berlin/Heidelberg, Germany: 2021. pp. 119&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-78787-5_16</ArticleId><ArticleId IdType="pubmed">35023098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffo P., Cavallaro S., Conforti F.L. The Advent of Omics Sciences in Clinical Trials of Motor Neuron Diseases. J. Pers. Med. 2022;12:758. doi: 10.3390/jpm12050758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050758</ArticleId><ArticleId IdType="pmc">PMC9144989</ArticleId><ArticleId IdType="pubmed">35629180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitropoulos K., Katsila T., Patrinos G.P., Pampalakis G. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis. OMICS A J. Integr. Biol. 2018;22:52&#x2013;64. doi: 10.1089/omi.2017.0183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2017.0183</ArticleId><ArticleId IdType="pubmed">29356625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedl T.J., Gil R.S., Cheng F., Rayner S.L., Davidson J.M., De Luca A., Villalva M.D., Ecroyd H., Walker A.K., Lee A. Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD. Front. Neurosci. 2019;13:548. doi: 10.3389/fnins.2019.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00548</ArticleId><ArticleId IdType="pmc">PMC6579929</ArticleId><ArticleId IdType="pubmed">31244593</ArticleId></ArticleIdList></Reference><Reference><Citation>Maz&#xf3;n M., Costa J.F.V., Ten-Esteve A., Mart&#xed;-Bonmat&#xed; L. Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis. Front. Neurosci. 2018;12:784. doi: 10.3389/fnins.2018.00784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00784</ArticleId><ArticleId IdType="pmc">PMC6209630</ArticleId><ArticleId IdType="pubmed">30410433</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson A.G., Oeckl P., Feneberg E., Bowser R., Otto M., Fischer R., Kessler B., Turner M.R. Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis. Expert Rev. Proteom. 2021;18:977&#x2013;994. doi: 10.1080/14789450.2021.2004890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2021.2004890</ArticleId><ArticleId IdType="pubmed">34758687</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell W.R., Kruse C.P.S., List E.O., Berryman D.E., Kopchick J.J. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J. Transl. Med. 2019;17:170. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Diekstra F.P., Harschnitz O., Westeneng H.-J., van Eijk K.R., Saris C.G.J., Groen E.J.N., van Es M.A., Blauw H.M., van Vught P.W.J., et al. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;13:e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N., Fagegaltier D., Harris B.T., Ostrow L.W., et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177.e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxi E.G., Thompson T., Li J., Kaye J.A., Lim R.G., Wu J., Ramamoorthy D., Lima L., Vaibhav V., Matlock A., et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat. Neurosci. 2022;25:226&#x2013;237. doi: 10.1038/s41593-021-01006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-01006-0</ArticleId><ArticleId IdType="pmc">PMC8825283</ArticleId><ArticleId IdType="pubmed">35115730</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia A.M., Gallo A., Manzari C., Raho S., Horner D.S., Chiara M., Valletti A., Aiello I., Mastropasqua F., Ciaccia L., et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 2017;7:10046. doi: 10.1038/s41598-017-10488-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Salomone S., D&#x2019;agata V., Conforti F.L., Cavallaro S. From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2020;14:577755. doi: 10.3389/fnins.2020.577755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.577755</ArticleId><ArticleId IdType="pmc">PMC7661549</ArticleId><ArticleId IdType="pubmed">33192262</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi F., Vakanski A. Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review. Bioengineering. 2023;10:173. doi: 10.3390/bioengineering10020173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bioengineering10020173</ArticleId><ArticleId IdType="pmc">PMC9952758</ArticleId><ArticleId IdType="pubmed">36829667</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran K.A., Kondrashova O., Bradley A., Williams E.D., Pearson J.V., Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13:152. doi: 10.1186/s13073-021-00968-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00968-x</ArticleId><ArticleId IdType="pmc">PMC8477474</ArticleId><ArticleId IdType="pubmed">34579788</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Zhang S., Tang Z., Wang H. Construction of gene-classifier and co-expression network analysis of genes in association with major depressive disorder. Psychiatry Res. 2020;293:113387. doi: 10.1016/j.psychres.2020.113387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113387</ArticleId><ArticleId IdType="pubmed">32823199</ArticleId></ArticleIdList></Reference><Reference><Citation>Falchetti M., Prediger R.D., Zanotto-Filho A. Classification algorithms applied to blood-based transcriptome meta-analysis to predict idiopathic Parkinson&#x2019;s disease. Comput. Biol. Med. 2020;124:103925. doi: 10.1016/j.compbiomed.2020.103925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2020.103925</ArticleId><ArticleId IdType="pubmed">32889300</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang X., Lin J., Li S., Deng G., Wei J. Classifiers for Predicting Coronary Artery Disease Based on Gene Expression Profiles in Peripheral Blood Mononuclear Cells. Int. J. Gen. Med. 2021;14:5651&#x2013;5663. doi: 10.2147/ijgm.s329005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijgm.s329005</ArticleId><ArticleId IdType="pmc">PMC8450378</ArticleId><ArticleId IdType="pubmed">34552349</ArticleId></ArticleIdList></Reference><Reference><Citation>Caball&#xe9;-Cervig&#xf3;n N., Castillo-Sequera J.L., G&#xf3;mez-Pulido J.A., G&#xf3;mez-Pulido J.M., Polo-Luque M.L. Machine Learning Applied to Diagnosis of Human Diseases: A Systematic Review. Appl. Sci. 2020;10:5135. doi: 10.3390/app10155135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app10155135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton J.J., Young A., Johnson M.J., Beattie R.M. Using machine learning to impact on long-term clinical care: Principles, challenges, and practicalities. Pediatr. Res. 2022;93:324&#x2013;333. doi: 10.1038/s41390-022-02194-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02194-6</ArticleId><ArticleId IdType="pmc">PMC9937918</ArticleId><ArticleId IdType="pubmed">35906306</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez G.A., Castillo R. Identification of Systemic Sclerosis through Machine Learning Algorithms and Gene Expression. Mathematics. 2022;10:4632. doi: 10.3390/math10244632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/math10244632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagh V.V., Agrawal S., Purohit S., Pachpor T., Narlikar L., Paralikar V., Khare S. Ensemble of machine learning based prediction methods for diagnosis of schizophrenia using peripheral blood gene expression profile. medRxiv. 2023 doi: 10.1101/2023.02.11.23285788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.11.23285788</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Napoli G., Verdile V., Morello G., Iemmolo R., Aronica E., Cavallaro S., Volont&#xe9; C. Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis. Front. Immunol. 2017;8:1689. doi: 10.3389/fimmu.2017.01689.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01689</ArticleId><ArticleId IdType="pmc">PMC5714870</ArticleId><ArticleId IdType="pubmed">29250069</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Guarnaccia M., Spampinato A.G., La Cognata V., D&#x2019;agata V., Cavallaro S. Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach. Mol. Neurobiol. 2017;55:1299&#x2013;1322. doi: 10.1007/s12035-017-0393-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0393-x</ArticleId><ArticleId IdType="pmc">PMC5820374</ArticleId><ArticleId IdType="pubmed">28120152</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Conforti F.L., D&#x2019;agata V., Cavallaro S. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach. J. Mol. Neurosci. 2017;61:563&#x2013;580. doi: 10.1007/s12031-017-0898-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-017-0898-9</ArticleId><ArticleId IdType="pmc">PMC5359376</ArticleId><ArticleId IdType="pubmed">28236105</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Cavallaro S. Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes. Front. Neurol. 2017;8:152. doi: 10.3389/fneur.2017.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00152</ArticleId><ArticleId IdType="pmc">PMC5395696</ArticleId><ArticleId IdType="pubmed">28469596</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Cavallaro S. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets. Mediat. Inflamm. 2017;2017:7070469. doi: 10.1155/2017/7070469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7070469</ArticleId><ArticleId IdType="pmc">PMC5610842</ArticleId><ArticleId IdType="pubmed">29081603</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Cavallaro S. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: Implications for personalized therapy. Futur. Med. Chem. 2015;7:1335&#x2013;1359. doi: 10.4155/fmc.15.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.15.60</ArticleId><ArticleId IdType="pubmed">26144267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., Morello G., La Cognata V., Guarnaccia M., Conforti F.L., Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. J. Pers. Med. 2022;12:770. doi: 10.3390/jpm12050770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050770</ArticleId><ArticleId IdType="pmc">PMC9143965</ArticleId><ArticleId IdType="pubmed">35629192</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Golini E., Iemmolo R., Balletta S., Morello G., De Rosa C., Villari A., Marinelli S., Vacca V., Bonaventura G., et al. CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neuron degeneration in vitro and improves neuromuscular function in SOD1G93A mice. Neurobiol. Dis. 2021;160:105538. doi: 10.1016/j.nbd.2021.105538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105538</ArticleId><ArticleId IdType="pubmed">34743985</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Morello G., Cavallaro S. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:4820. doi: 10.3390/ijms22094820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094820</ArticleId><ArticleId IdType="pmc">PMC8125201</ArticleId><ArticleId IdType="pubmed">34062930</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Morello G., Spampinato A.G., Amadio S., Apolloni S., D&#x2019;agata V., Cavallaro S. Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS. Ageing Res. Rev. 2020;62:101121. doi: 10.1016/j.arr.2020.101121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101121</ArticleId><ArticleId IdType="pubmed">32653439</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Gentile G., Aronica E., Cavallaro S. Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions. Cells. 2020;9:159. doi: 10.3390/cells9010159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010159</ArticleId><ArticleId IdType="pmc">PMC7017305</ArticleId><ArticleId IdType="pubmed">31936368</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Baas F., Iyer A., Asbroek A.L.T., Morello G., Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 2014;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Amadio S., Fabbrizio P., Morello G., Spampinato A.G., Latagliata E.C., Salvatori I., Proietti D., Ferri A., Madaro L., et al. Histaminergic transmission slows progression of amyotrophic lateral sclerosis. J. Cachex- Sarcopenia Muscle. 2019;10:872&#x2013;893. doi: 10.1002/jcsm.12422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12422</ArticleId><ArticleId IdType="pmc">PMC6711424</ArticleId><ArticleId IdType="pubmed">31020811</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Conforti F.L., Cavallaro S. Taxonomy Meets Neurology, the Case of Amyotrophic Lateral Sclerosis. Front. Neurosci. 2018;12:673. doi: 10.3389/fnins.2018.00673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00673</ArticleId><ArticleId IdType="pmc">PMC6168652</ArticleId><ArticleId IdType="pubmed">30319346</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Guarnaccia M., Spampinato A.G., Salomone S., D&#x2019;agata V., Conforti F.L., Aronica E., Cavallaro S. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Sci. Rep. 2019;9:9968. doi: 10.1038/s41598-019-46355-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46355-w</ArticleId><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro C., Sprovieri T., Morello G., Perrone B., Spampinato A.G., Simone I.L., Trojsi F., Monsurr&#xf2; M.R., Spataro R., La Bella V., et al. Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: A two-decade analysis. Neurobiol. Aging. 2020;99:99.e7&#x2013;99.e14. doi: 10.1016/j.neurobiolaging.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.017</ArticleId><ArticleId IdType="pubmed">32951934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves C.J., Dariolli R., Jorge F.M., Monteiro M.R., Maximino J.R., Martins R.S., Strauss B.E., Krieger J.E., Callegaro D., Chadi G. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front. Cell. Neurosci. 2015;9:289. doi: 10.3389/fncel.2015.00289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00289</ArticleId><ArticleId IdType="pmc">PMC4523944</ArticleId><ArticleId IdType="pubmed">26300727</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Allen S.P., Goodall E.F., Kramer S., Ponger L.-L., Heath P.R., Milo M., Hollinger H.C., Walsh T., Highley J.R., et al. Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincecum J.M., Vieira F.G., Wang M.Z., Thompson K., De Zutter G.S., Kidd J., Moreno A., Sanchez R., Carrion I.J., A Levine B., et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat. Genet. 2010;42:392&#x2013;399. doi: 10.1038/ng.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.557</ArticleId><ArticleId IdType="pubmed">20348957</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F., Fujimura C., Ishida S., Nakajima H., Furutama D., Uehara H., Shinoda K., Sugino M., Hanafusa T. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello M.L., Di Fini F., Notaro A., Spataro R., Conforti F.L., La Bella V. ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic FUS P525L Mutation Carriers. Neurodegener. Dis. 2017;17:292&#x2013;303. doi: 10.1159/000480085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000480085</ArticleId><ArticleId IdType="pubmed">29035885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetoni A.R., Zorzi V., Paciello F., Ziraldo G., Peres C., Raspa M., Scavizzi F., Salvatore A.M., Crispino G., Tognola G., et al. Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway. Redox Biol. 2018;19:301&#x2013;317. doi: 10.1016/j.redox.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.08.002</ArticleId><ArticleId IdType="pmc">PMC6129666</ArticleId><ArticleId IdType="pubmed">30199819</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P., et al. The STRING database in 2021: Customizable protein&#x2013;protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2020;49:D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Mering C., Huynen M., Jaeggi D., Schmidt S., Bork P., Snel B. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258&#x2013;261. doi: 10.1093/nar/gkg034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg034</ArticleId><ArticleId IdType="pmc">PMC165481</ArticleId><ArticleId IdType="pubmed">12519996</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C.-H., Chen S.-H., Wu H.-H., Ho C.-W., Ko M.-T., Lin C.-Y. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 2014;8((Suppl. S4)):S11. doi: 10.1186/1752-0509-8-S4-S11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Maere S., Heymans K., Kuiper M. BiNGO: A Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks. Bioinformatics. 2005;21:3448&#x2013;3449. doi: 10.1093/bioinformatics/bti551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bti551</ArticleId><ArticleId IdType="pubmed">15972284</ArticleId></ArticleIdList></Reference><Reference><Citation>Won Y.H., Lee M.-Y., Choi Y.-C., Ha Y., Kim H., Kim D.-Y., Kim M.-S., Yu J.H., Seo J.H., Kim M., et al. Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis. PLoS ONE. 2016;11:e0165290. doi: 10.1371/journal.pone.0165290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165290</ArticleId><ArticleId IdType="pmc">PMC5094695</ArticleId><ArticleId IdType="pubmed">27812125</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;nberg A., Skene N., Sanders F., Trusohamn M., Remnest&#xe5;l J., Szczepi&#x144;ska A., Aksoylu I.S., L&#xf6;nnerberg P., Ebarasi L., Wouters S., et al. Altered perivascular fibroblast activity precedes ALS disease onset. Nat. Med. 2021;27:640&#x2013;646. doi: 10.1038/s41591-021-01295-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01295-9</ArticleId><ArticleId IdType="pmc">PMC7613336</ArticleId><ArticleId IdType="pubmed">33859435</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Kawamata H., Bredvik K.G., Arreguin A.J., Cajamarca S.A., Hupf J.C., Ravits J.M., Miller T.M., Maragakis N.J., Hales C.M., et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol. Neurodegener. 2017;12:76. doi: 10.1186/s13024-017-0217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>A Fels J., Casalena G., Konrad C., E Holmes H., Dellinger R.W., Manfredi G. Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301. Hum. Mol. Genet. 2022;31:3458&#x2013;3477. doi: 10.1093/hmg/ddac118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac118</ArticleId><ArticleId IdType="pmc">PMC9558834</ArticleId><ArticleId IdType="pubmed">35652455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumbier K., Roth M., Li Z., Lazzari-Dean J., Waters C., Huang P., Korobeynikov V., York N., Consortium G.C., Phatnani H., et al. A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblasts. bioRxiv. 2022 doi: 10.1101/2022.09.27.509770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.27.509770</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Mullen B., Wojtas A., Heckman M.G., Diehl N.N., Baker M.C., DeJesus-Hernandez M., Brown P.H., E Murray M., Hsiung G.-Y.R., et al. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol. Neurodegener. 2014;9:38. doi: 10.1186/1750-1326-9-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-38</ArticleId><ArticleId IdType="pmc">PMC4190282</ArticleId><ArticleId IdType="pubmed">25239657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D., Hu H., Munsat T., Shefner J., Taylor J., Sandler D. Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2005;2:195&#x2013;201. doi: 10.1159/000089625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089625</ArticleId><ArticleId IdType="pubmed">16909025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., A Lehman T., Park L.P., Munsat T.L., Shefner J.M., Sandler D.P., Hu H., Taylor J.A. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: Polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ. Health Perspect. 2003;111:1335&#x2013;1339. doi: 10.1289/ehp.6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.6109</ArticleId><ArticleId IdType="pmc">PMC1241615</ArticleId><ArticleId IdType="pubmed">12896855</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A.C., Manzano R., Atencia-Cibreiro G., Oliv&#xe1;n S., Mu&#xf1;oz M.J., Zaragoza P., Cordero-V&#xe1;zquez P., Esteban-P&#xe9;rez J., Garc&#xed;a-Redondo A., Osta R. Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice. PLoS ONE. 2012;7:e32632. doi: 10.1371/journal.pone.0032632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032632</ArticleId><ArticleId IdType="pmc">PMC3296719</ArticleId><ArticleId IdType="pubmed">22412900</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;ger B., Vergani L., Sorar&#xf9; G., Hespel P., Derave W., Gobelet C., D&#x2019;Ascenzio C., Angelini C., Russell A.P. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585. doi: 10.1096/fj.05-5249fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5249fje</ArticleId><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z., Liu L., Tao Z., Wang R., Ren H., Sun H., Lin Z., Zhang Z., Mu C., Zhou J., et al. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat. Commun. 2019;10:2906. doi: 10.1038/s41467-019-10956-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaliszewska A., Allison J., Col T.-T., Shaw C., Arias N. Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD&#x2014;A Systematic Review and Meta-Analysis. Cerebellum. 2021;21:681&#x2013;714. doi: 10.1007/s12311-021-01320-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-021-01320-0</ArticleId><ArticleId IdType="pmc">PMC9325807</ArticleId><ArticleId IdType="pubmed">34491551</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw H.M., Al-Chalabi A., Andersen P.M., van Vught P.W., Diekstra F.P., van Es M.A., Saris C.G., Groen E.J., van Rheenen W., Koppers M., et al. A large genome scan for rare CNVs in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2010;19:4091&#x2013;4099. doi: 10.1093/hmg/ddq323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq323</ArticleId><ArticleId IdType="pubmed">20685689</ArticleId></ArticleIdList></Reference><Reference><Citation>Locke D.P., Sharp A.J., McCarroll S.A., McGrath S.D., Newman T.L., Cheng Z., Schwartz S., Albertson D.G., Pinkel D., Altshuler D.M., et al. Linkage Disequilibrium and Heritability of Copy-Number Polymorphisms within Duplicated Regions of the Human Genome. Am. J. Hum. Genet. 2006;79:275&#x2013;290. doi: 10.1086/505653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/505653</ArticleId><ArticleId IdType="pmc">PMC1559496</ArticleId><ArticleId IdType="pubmed">16826518</ArticleId></ArticleIdList></Reference><Reference><Citation>A van Es M., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Bosch L.V.D., de Jong S.W., de Jong V., Baas F., Slot R.V., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2007;40:29&#x2013;31. doi: 10.1038/ng.2007.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2007.52</ArticleId><ArticleId IdType="pubmed">18084291</ArticleId></ArticleIdList></Reference><Reference><Citation>Myszczynska M., Ferraiuolo L. New In Vitro Models to Study Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26:258&#x2013;265. doi: 10.1111/bpa.12353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12353</ArticleId><ArticleId IdType="pmc">PMC8029155</ArticleId><ArticleId IdType="pubmed">26780562</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P., Moreno J., Aso E., Povedano M., Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: Implications in frontotemporal lobar degeneration. Aging. 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo G.M., Granatiero V., Kawamata H., Konrad C., Kim M., Arreguin A., Zhao D., A Milner T., Manfredi G. Parkin is a disease modifier in the mutant SOD 1 mouse model of ALS. EMBO Mol. Med. 2018;10:e8888. doi: 10.15252/emmm.201808888.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201808888</ArticleId><ArticleId IdType="pmc">PMC6180298</ArticleId><ArticleId IdType="pubmed">30126943</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn P.M.J., Moreira P.I., Ambr&#xf3;sio A.F., Alves C.H. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol. Commun. 2020;8:189. doi: 10.1186/s40478-020-01062-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01062-w</ArticleId><ArticleId IdType="pmc">PMC7654589</ArticleId><ArticleId IdType="pubmed">33168089</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Li M., Ji Y., Zhu J., Chen Z., Zhang L., Deng C., Cheng Q., Wang W., Shen Y., et al. Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis. Antioxidants. 2022;11:303. doi: 10.3390/antiox11020303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11020303</ArticleId><ArticleId IdType="pmc">PMC8868268</ArticleId><ArticleId IdType="pubmed">35204186</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J. Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:340&#x2013;351. doi: 10.1007/s13311-015-0340-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0340-3</ArticleId><ArticleId IdType="pmc">PMC4404431</ArticleId><ArticleId IdType="pubmed">25689976</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Strong M.J. Oxford University Press; Oxford, UK: 2012. Perturbed RNA Metabolism in Amyotrophic Lateral Sclerosis; pp. 353&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/med/9780199590674.003.0022</ArticleId></ArticleIdList></Reference><Reference><Citation>Laneve P., Tollis P., Caffarelli E. RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective. Int. J. Mol. Sci. 2021;22:10285. doi: 10.3390/ijms221910285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910285</ArticleId><ArticleId IdType="pmc">PMC8508793</ArticleId><ArticleId IdType="pubmed">34638636</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.M., Cannavino J., Li H., Anderson K.M., Nelson B.R., McAnally J., Bezprozvannaya S., Liu Y., Lin W., Liu N., et al. Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106. Proc. Natl. Acad. Sci. USA. 2016;113:201608423-503. doi: 10.1073/pnas.1608423113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1608423113</ArticleId><ArticleId IdType="pmc">PMC4978283</ArticleId><ArticleId IdType="pubmed">27418600</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce P.I., Fratta P., Landman A.S., Mcgoldrick P., Wackerhage H., Groves M., Busam B.S., Galino J., Corrochano S., Beskina O.A., et al. Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration. Hum. Mol. Genet. 2015;25:291&#x2013;307. doi: 10.1093/hmg/ddv471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv471</ArticleId><ArticleId IdType="pmc">PMC4706115</ArticleId><ArticleId IdType="pubmed">26604141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash B.P., Naumann M., Sterneckert J., Hermann A. Genome Wide Analysis Points towards Subtype-Specific Diseases in Different Genetic Forms of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:6938. doi: 10.3390/ijms21186938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186938</ArticleId><ArticleId IdType="pmc">PMC7555318</ArticleId><ArticleId IdType="pubmed">32967368</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu S., Lv Y., Liu Y., Qiao S., Wang H. Zinc Finger Proteins in Neuro-Related Diseases Progression. Front. Neurosci. 2021;15:760567. doi: 10.3389/fnins.2021.760567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.760567</ArticleId><ArticleId IdType="pmc">PMC8637543</ArticleId><ArticleId IdType="pubmed">34867169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru&#xe9; L., Oeckl P., Timmers M., Lenaerts A., van der Vos J., Smolders S., Poppe L., de Boer A., Bosch L.V.D., Van Damme P., et al. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2019;7:114. doi: 10.1186/s40478-019-0759-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0759-6</ArticleId><ArticleId IdType="pmc">PMC6626434</ArticleId><ArticleId IdType="pubmed">31300041</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Pang D., Li C., Gu X., Chen Y., Ou R., Wei Q., Shang H. The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients. Mol. Neurobiol. 2022;59:3678&#x2013;3689. doi: 10.1007/s12035-022-02789-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02789-4</ArticleId><ArticleId IdType="pubmed">35364800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Gray E., Thompson A.G., Talbot K., Leigh P.N., Newbury S.F., Turner M.R., Hafezparast M. Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Ann. Med. 2022;54:3068&#x2013;3077. doi: 10.1080/07853890.2022.2138530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2138530</ArticleId><ArticleId IdType="pmc">PMC9629092</ArticleId><ArticleId IdType="pubmed">36314539</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Gray E., Thompson A.G., Bobeva Y., Talbot K., Weishaupt J., Ludolph A., Malaspina A., Leigh P.N., Newbury S.F., et al. Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa053. doi: 10.1093/braincomms/fcaa053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa053</ArticleId><ArticleId IdType="pmc">PMC7329382</ArticleId><ArticleId IdType="pubmed">32613197</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K.-W., Chen J.-A. Functional Roles of Long Non-coding RNAs in Motor Neuron Development and Disease. J. Biomed. Sci. 2020;27:38. doi: 10.1186/s12929-020-00628-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00628-z</ArticleId><ArticleId IdType="pmc">PMC7041250</ArticleId><ArticleId IdType="pubmed">32093746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamoor S. Differential expression of PSMD5-AS1 in amyotrophic lateral sclerosis. OSF. 2022 doi: 10.31219/OSF.IO/BT2QZ. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.31219/OSF.IO/BT2QZ</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A.R., Wang Q., Meechoovet B., Siniard A.L., Naymik M., De Both M., Huentelman M.J., Caselli R.J., Driver-Dunckley E., Dunckley T. DNA Methylation and Expression Profiles of Whole Blood in Parkinson&#x2019;s Disease. Front. Genet. 2021;12:640266. doi: 10.3389/fgene.2021.640266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.640266</ArticleId><ArticleId IdType="pmc">PMC8107387</ArticleId><ArticleId IdType="pubmed">33981329</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X., Liu Y., Zhang T., Cong S. Integrated analysis of differentially expressed genes and construction of a competing endogenous RNA network in human Huntington neural progenitor cells. BMC Med. Genom. 2021;14:48. doi: 10.1186/s12920-021-00894-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-021-00894-2</ArticleId><ArticleId IdType="pmc">PMC7881634</ArticleId><ArticleId IdType="pubmed">33579286</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R.J. Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;137:859&#x2013;877. doi: 10.1007/s00401-019-01964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01964-7</ArticleId><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A., Paul J.W., Gitler A.D. Nuclear transport dysfunction: A common theme in amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurochem. 2016;138:134&#x2013;144. doi: 10.1111/jnc.13642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13642</ArticleId><ArticleId IdType="pubmed">27087014</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target? Cell Biosci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front. Neurosci. 2017;10:611. doi: 10.3389/fnins.2016.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean M., L&#xf3;pez-D&#xed;ez R., Vasquez C., Gugger P.F., Schmidt A.M. Neuronal&#x2013;glial communication perturbations in murine SOD1G93A spinal cord. Commun. Biol. 2022;5:177. doi: 10.1038/s42003-022-03128-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03128-y</ArticleId><ArticleId IdType="pmc">PMC8885678</ArticleId><ArticleId IdType="pubmed">35228715</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin S.J., Kim J.M.H., Baughn M., Libby R.T., Kim Y.J., Fan Y., Libby R.T., La Spada A., Stone B., Ravits J. Sporadic ALS has compartment-specific aberrant exon splicing and altered cell&#x2013;matrix adhesion biology. Hum. Mol. Genet. 2010;19:313&#x2013;328. doi: 10.1093/hmg/ddp498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp498</ArticleId><ArticleId IdType="pmc">PMC2796893</ArticleId><ArticleId IdType="pubmed">19864493</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Heath P.R., Holden H., Kasher P., Bender F.L., Claes F., Lambrechts D., Sendtner M., Carmeliet P., Shaw P.J. Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGF&#x3b4;/&#x3b4; mouse model of amyotrophic lateral sclerosis. BMC Genom. 2010;11:203. doi: 10.1186/1471-2164-11-203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-11-203</ArticleId><ArticleId IdType="pmc">PMC2861063</ArticleId><ArticleId IdType="pubmed">20346106</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszlo Z.I., Hindley N., Avila A.S., Kline R.A., Eaton S.L., Lamont D.J., Smith C., Spires-Jones T.L., Wishart T.M., Henstridge C.M. Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex. Acta Neuropathol. Commun. 2022;10:156. doi: 10.1186/s40478-022-01455-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01455-z</ArticleId><ArticleId IdType="pmc">PMC9618182</ArticleId><ArticleId IdType="pubmed">36309735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Marino M., Cheroni C., Fontana E., Crippa V., Poletti A., De Biasi S. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response. Prog. Neurobiol. 2012;97:101&#x2013;126. doi: 10.1016/j.pneurobio.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.10.001</ArticleId><ArticleId IdType="pubmed">22033150</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J.N., Koppers M., Berg L.H.v.D., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury J., Chisholm C., Lum J., Farrawell N. Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis? Neural Regen. Res. 2022;17:2218&#x2013;2220. doi: 10.4103/1673-5374.335786.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.335786</ArticleId><ArticleId IdType="pmc">PMC9083156</ArticleId><ArticleId IdType="pubmed">35259837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk S.E., Tracey T.J., Steyn F., Ngo S.T. Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Front. Neurol. 2019;10:191. doi: 10.3389/fneur.2019.00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00191</ArticleId><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbernagel N., Walecki M., Sch&#xe4;fer M.K.-H., Kessler M., Zobeiri M., Rinn&#xe9; S., Kiper A.K., Komadowski M.A., Vowinkel K.S., Wemh&#xf6;ner K., et al. The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function. FASEB J. 2018;32:6159&#x2013;6173. doi: 10.1096/fj.201800246R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201800246R</ArticleId><ArticleId IdType="pmc">PMC6629115</ArticleId><ArticleId IdType="pubmed">29879376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M., Malleret G., Dudman J., Buhl D., Santoro B., Gibbs E., Vronskaya S., Buzsaki G., Siegelbaum S., Kandel E. A Behavioral Role for Dendritic IntegrationHCN1 Channels Constrain Spatial Memory and Plasticity at Inputs to Distal Dendrites of CA1 Pyramidal Neurons. Cell. 2004;119:719&#x2013;732. doi: 10.1016/S0092-8674(04)01055-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(04)01055-4</ArticleId><ArticleId IdType="pubmed">15550252</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Venugopal S., Majid S., Ahn I.S., Diamante G., Hong J., Yang X., Chandler S.H. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Neurobiol. Dis. 2020;141:104877. doi: 10.1016/j.nbd.2020.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104877</ArticleId><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>